期刊
NATURE REVIEWS IMMUNOLOGY
卷 10, 期 8, 页码 554-567出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nri2808
关键词
-
类别
资金
- Cancer Research Institute
- NCI [P50 CA121974]
- PEW Charitable Trust
- NIH [CA121974, DK051665]
- JDRF [32-2008-352]
Transforming growth factor-beta (TGF beta) is an immunosuppressive cytokine produced by tumour cells and immune cells that can polarize many components of the immune system. This Review covers the effects of TGF beta on natural killer (NK) cells, dendritic cells, macrophages, neutrophils, CD8(+) and CD4(+) effector and regulatory T cells, and NKT cells in animal tumour models and in patients with cancer. Collectively, many recent studies favour the hypothesis that blocking TGF beta-induced signalling in the tumour microenvironment enhances antitumour immunity and may be beneficial for cancer therapy. An overview of the current drugs and reagents available for inhibiting TGF beta-induced signalling and their phase in clinical development is also provided.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据